Author: admin

2023-05-30T08:01:00

(BPT) – Meet Chris Wright, a professional basketball player and father of three who has played for teams across the world. Chris never imagined relapsing multiple sclerosis (RMS), a chronic and unpredictable disease where the immune system attacks healthy tissues in the central nervous system (CNS), would be part of his story. He was completely shocked when he was diagnosed with this lifelong condition while playing in Turkey in 2012.

One day after practice, Chris noticed a tingling in his right foot, but he quickly chalked it up to overuse. However, within a day, the sensation spread to his right arm, hand, and leg. Suddenly, Chris couldn’t get out of bed or walk and fell to the floor. After being taken to the hospital and confined to a wheelchair, he was diagnosed with RMS by a specialist in Istanbul, Turkey.

“I was heartbroken when I was diagnosed with RMS,” Chris said. “I didn’t know much about RMS and was completely overwhelmed. I was just trying to learn as much as possible about it and knew I had to go home and figure this out the best I could with my family,” he said.

Chris was suddenly faced with the uncertainty that many in the RMS community know too well. His hard work, well-being, and identity had changed overnight.

The Support of His Family, Friends, Coaches, and Doctor

Immediately after receiving his diagnosis, Chris returned home to the United States to be surrounded by his support network. While several doctors told him to retire, his current neurologist, MS specialist Heidi Crayton, MD, was more positive about Chris’s future.

“Your relationship with your neurologist is extremely vital,” Chris said. “When I met Dr. Crayton, I was really down, but she was extremely optimistic. You have to find a doctor who will be supportive and honest with you. Dr. Crayton helped me develop a game plan that has led me to where I am now,” he said.

Dr. Crayton encouraged Chris to express his feelings and concerns, which in turn, helped her recommend treatment options to help manage his RMS symptoms throughout his disease journey. “I encourage my patients to feel empowered to express themselves during an appointment so we can talk through their concerns and make sure they are on a treatment plan that is right for them,” Dr. Crayton said.

“In addition to what testing reveals, there are other factors to consider when deciding what RMS medication to recommend, including lifestyle, which is why it’s so important to get to know the patient,” she added.

Choosing the Right RMS Treatment

After almost a decade on therapy, Chris’s treatment was no longer working well for him, and he voiced to his neurologist that he wanted a change. As a result, Dr. Crayton suggested MAVENCLAD^® (cladribine tablets), which consisted of 10 days of treatment per year for a two-year period.

MAVENCLAD is a prescription medicine used to treat relapsing forms of RMS, to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, MAVENCLAD is generally used in people who have tried another RMS medicine that they could not tolerate or that has not worked well enough. MAVENCLAD is not recommended for use in people with clinically isolated syndrome.

MAVENCLAD can cause serious side effects including the risk of cancer (malignancies) and risk of birth defects if used during pregnancy. Females must not be pregnant when they start treatment with MAVENCLAD or become pregnant during MAVENCLAD dosing and within six months after the last dose of each yearly treatment course. For males with female partners who are able to become pregnant, effective birth control should be used during the days on which MAVENCLAD is taken and for at least 6 months after the last dose of each yearly treatment course. Additional serious side effects can include low blood cell counts, serious infections such as TB, hepatitis B or C, shingles, or progressive multifocal leukoencephalopathy, liver problems, allergic reactions, and heart failure. The most common side effects of MAVENCLAD include upper respiratory infection, headache, and low white blood cell count.

Before starting treatment, Dr. Crayton explained the serious side effects of MAVENCLAD, including the risk of cancer and birth defects. Other side effects include low white blood cell counts, serious infections, and liver problems. Following discussion of the treatment’s dosing and safety information with Dr. Crayton, Chris was ready to try MAVENCLAD. After completing initial screening and education, including using effective contraception and the need for ongoing monitoring and doctor visits, Chris began treatment with MAVENCLAD.

Chris finished his second year of treatment with MAVENCLAD, and so far, the treatment has worked well for him. Several factors, including, a healthy lifestyle, MAVENCLAD, and strong communication with Dr. Crayton have thus far allowed Chris to continue playing the sport he loves.

However, each individual is different, and results may vary. It’s important for patients to talk thoroughly with their healthcare provider about their symptoms and treatment plan for the best possible outcome.

Express4MS and the Importance of Expressing Yourself

In 2022, Chris joined forces with EMD Serono to take part in their Express4MS initiative, where he shared his story about living with RMS. Express4MS gives visibility to the journeys of people living with RMS and encourages them to express themselves, not only within their community but also with their healthcare providers. This allows for their voices to be heard when it comes to managing their condition.

Chris admitted that it took him some time to realize that RMS doesn’t define him after receiving the diagnosis. He emphasized that the support of family, friends, and his doctor was the “lifeline” that helped him continue to express himself.

“As someone who has been living with RMS for ten years, I know first-hand the impact it can have on all aspects of a person’s life,” Chris said. “I hope by sharing my experience, I can help empower others living with RMS to express themselves too, with their friends, family, and even their healthcare providers,” he added.

To hear stories from a diverse group of people about their experiences living with RMS and how they’ve learned to express themselves with their loved ones, the RMS community, their healthcare providers, and the world, visit Express4MS.com.

What is MAVENCLAD?

MAVENCLAD is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, MAVENCLAD is generally used in people who have tried another MS medicine that they could not tolerate or that has not worked well enough.

MAVENCLAD is not recommended for use in people with clinically isolated syndrome (CIS).

It is not known if MAVENCLAD is safe and effective in children under 18 years of age and is therefore not recommended.

MAVENCLAD may cause serious side effects, including:

• Risk of cancer (malignancies). You should follow healthcare provider instructions about screening for cancer.
• MAVENCLAD may cause birth defects if used during pregnancy. Females must not be pregnant when they start treatment with MAVENCLAD or become pregnant during MAVENCLAD dosing and within 6 months after the last dose of each yearly treatment course. You should stop treatment with MAVENCLAD and contact your healthcare provider right away if you become pregnant during treatment with MAVENCLAD.
• For females who are able to become pregnant:
  • Your healthcare provider should order a pregnancy test before you begin your first and second yearly treatment course of MAVENCLAD to make sure that you are not pregnant.
  • Use effective birth control (contraception) on the days on which you take MAVENCLAD and for at least 6 months after the last dose of each yearly treatment course.
    • Talk to your healthcare provider if you use oral contraceptives (the “pill”).
    • You should use a second method of birth control on the days on which you take MAVENCLAD and for at least 4 weeks after your last dose of each yearly treatment course.
• For males with female partners who are able to become pregnant:
  • Use effective birth control (contraception) during the days on which you take MAVENCLAD and for at least 6 months after the last dose of each yearly treatment course.

Do not take MAVENCLAD if you:

• have cancer (malignancy).
• are pregnant, plan to become pregnant, or are a woman of childbearing age or a man able to father a child and you are not using birth control.
• are breastfeeding.
• are human immunodeficiency virus (HIV) positive.
• have active infections, including tuberculosis (TB), hepatitis B or C.
• are allergic to cladribine.

Before you take MAVENCLAD, tell your healthcare provider about all of your medical conditions, including if you:

• think you have an infection.
• have taken, take, or plan to take medicines that affect your immune system or blood cells, or other treatments for MS. Certain medicines can increase your risk of getting an infection.
• have had a recent vaccination or are scheduled to receive any vaccinations. You should not receive live or live-attenuated vaccines within the 4 to 6 weeks preceding treatment with MAVENCLAD or receive these types of vaccines during your treatment with MAVENCLAD and unless directed by your healthcare provider.
• have heart failure.
• have or have had cancer.
• have liver or kidney problems.
• are breastfeeding or plan to breastfeed. It is not known if MAVENCLAD passes into your breast milk. Do not breastfeed on the days on which you take MAVENCLAD, and for 10 days after the last dose.

How should I take MAVENCLAD?

• MAVENCLAD is given as two yearly treatment courses.
• Each yearly treatment course consists of 2 treatment weeks (also called cycles) that will be about a month apart.
• Take MAVENCLAD with water and swallow whole without chewing. MAVENCLAD can be taken with or without food.
• Swallow MAVENCLAD right away after opening the blister pack.
• Your hands must be dry when handling MAVENCLAD and washed well with water afterwards.
• Limit contact with your skin. Avoid touching your nose, eyes and other parts of the body. If you get MAVENCLAD on your skin or on any surface, wash it right away with water.
• Take MAVENCLAD at least 3 hours apart from other medicines taken by mouth during the 4- to 5-day MAVENCLAD treatment week.
• If you miss a dose, take it as soon as you remember on the same day. If the whole day passes before you remember, take your missed dose the next day. Do not take 2 doses at the same time. Instead, you will extend the number of days in that treatment week.

Your healthcare provider will continue to monitor your health during the 2 yearly treatment courses, and for at least another 2 years during which you do not need to take MAVENCLAD. It is not known if MAVENCLAD is safe and effective in people who restart MAVENCLAD treatment more than 2 years after completing 2 yearly treatment courses.

MAVENCLAD can cause serious side effects. If you have any of these symptoms listed below, call your healthcare provider right away:

• low blood cell counts have happened and can increase your risk of infections during treatment with MAVENCLAD. Blood tests are needed before you start treatment with MAVENCLAD, during your treatment with MAVENCLAD, and afterward, as needed.
• serious infections such as:
  • TB, hepatitis B or C, and shingles (herpes zoster). Fatal cases of TB and hepatitis have happened with cladribine during clinical studies. Tell your healthcare provider right away if you get any symptoms of the following infection related problems or if any of the symptoms get worse, including: fever, aching painful muscles, headache, feeling of being generally unwell, loss of appetite, burning, tingling, numbness or itchiness of the skin in the affected area, skin blotches, blistered rash, or severe pain.
  • progressive multifocal leukoencephalopathy (PML). PML is a rare brain infection that usually leads to death or severe disability. Although PML has not been seen in MS patients taking MAVENCLAD, it may happen in people with weakened immune systems. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These may include: weakness on 1 side of your body, loss of coordination in your arms and legs, decreased strength, problems with balance, changes in your vision, changes in your thinking or memory, confusion, or changes in your personality.
• liver problems. Blood tests should be performed to check your liver before you start taking MAVENCLAD. Symptoms of liver problems may include: nausea, vomiting, stomach pain, tiredness, loss of appetite, dark urine, or your skin or the whites of your eyes turn yellow.
• allergic reactions (hypersensitivities). You should stop treatment and seek immediate medical attention if any signs or symptoms of allergic reactions occur. Symptoms of an allergic reaction may include: skin rash, swelling or itching of the face, lips, tongue or throat, or trouble breathing.
• heart failure. MAVENCLAD may cause heart failure, which means your heart may not pump as well as it should. Call your healthcare provider or go to the closest emergency room for medical help right away if you have any signs or symptoms such as shortness of breath, a fast or irregular heart beat, or unusual swelling in your body.

The most common side effects of MAVENCLAD include: upper respiratory infection, headache, and low white blood cell counts.

These are not all the possible side effects of MAVENCLAD. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the full Prescribing Information/Medication Guide, including serious side effects, for additional Important Safety Information.

Chris and Dr. Crayton are sponsored by EMD Serono, Inc.

EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada.

MAVENCLAD is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.

US-MAV-02045 May 2023 Intended for US only

2023-05-30T09:01:00

(BPT) – This content is sponsored and provided by Myovant Sciences and Pfizer Inc.

After retiring, Mike settled into Arlington, Virginia, right outside of Washington, D.C., where he was a teacher for many years. He spends most of his days exercising, watching baseball, spending summers in Maine and enjoying adventures with his partner of 33 years, Cindy. But in October 2020, in the midst of the pandemic, Mike found himself embarking on an unexpected journey.

During a routine physical, Mike shared with his doctor that he was experiencing frequent urination, which he deduced was part of getting older. Further examination found nodules on his prostate, and the doctor ordered a prostate-specific antigen (PSA) test in which Mike’s result was higher than the normal range. While he tried to stay calm, he could not help but think about his family history with cancer and whether he was about to be impacted. He was referred to a urologist and then an oncologist, who confirmed that not only did he have prostate cancer, it was advanced.

Approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is the most common form of cancer in American men, other than skin cancer, and is the second leading cause of cancer death for men in the U.S. Prostate cancer is considered advanced if it is recurrent (meaning it has returned after initial treatment), locally advanced (meaning it has spread to tissues near the prostate) or metastatic (meaning it has spread to other parts of the body).

After his diagnosis, Mike began treatment, which included the use of androgen deprivation therapy, or ADT, which can lower levels of testosterone — a hormone that most prostate cancers need to grow. He also began his own research on advanced prostate cancer and came upon a presentation by an oncologist discussing a prescription medicine used in adults for the treatment of advanced prostate cancer called ORGOVYX^® (relugolix), a different kind of ADT that is a pill, not an injection. After weighing the potential risks and benefits with Cindy, Mike talked to his oncologist about the therapy and, together, they decided to begin his treatment with ORGOVYX. Side effects differ from patient to patient, but among those Mike experienced, the most noticeable was fatigue. Please see Important Safety Information below.

Despite the setback of his diagnosis and the added challenges of receiving treatment during a pandemic, his support system kept him going, particularly Cindy and his children. He joined support groups, which offered perspectives from those in various stages of their journey, but most of all, provided community. What was also important is the partnership with his oncologist that has allowed him to take an active role in his treatment.

Mike continues to maintain a positive outlook. He states, “There is nothing in this life that you should leave unsaid or undone, especially for those you love and care about. There is always hope — whether unlikely or expected.”

IMPORTANT SAFETY INFORMATION AND USE

Do not take ORGOVYX if you have had a severe allergic reaction to relugolix or any of the ingredients in ORGOVYX.

What should I tell my healthcare provider before taking ORGOVYX?

Tell your healthcare provider about all of your medical conditions, including if you:

• Have any heart problems, including a condition called long QT syndrome.
• Are pregnant or plan to become pregnant. ORGOVYX can harm your unborn baby and cause loss of pregnancy (miscarriage).
• Have a partner who is pregnant or may become pregnant.
• Males who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ORGOVYX and for 2 weeks after the last dose of ORGOVYX.
• Are breastfeeding or plan to breastfeed. It is not known if ORGOVYX passes into your breast milk.

Tell your healthcare provider about all the medicines or treatments you receive, including: prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking ORGOVYX with certain other medicines can affect how ORGOVYX works or may cause side effects.

You should not start or stop any medicine before you talk with your healthcare provider who prescribed ORGOVYX.

What are the possible side effects of ORGOVYX?

Serious side effects of ORGOVYX include:

• Changes in the electrical activity of your heart (QT prolongation). Your healthcare provider may check your body salts (electrolytes) and the electrical activity of your heart during treatment with ORGOVYX. Tell your healthcare provider right away if you get any signs or symptoms of QT prolongation, including:

dizziness fainting

feeling that your heart is pounding or racing (palpitations) chest pain

• Allergic reactions. Stop taking ORGOVYX and tell your healthcare provider or get emergency medical help right away if you get any signs or symptoms of an allergic reaction, including:
  • swelling of your face, lips, tongue, throat, or trouble swallowing
  • trouble breathing
  • hives (raised bumps), rash, or redness all over your body

Most common side effects of ORGOVYX include:

hot flushes increased blood sugar levels increased blood fat (triglyceride) levels muscle and joint pain decreased blood hemoglobin levels

increased liver enzymes tiredness constipation diarrhea

ORGOVYX may cause other side effects including weight gain, decreased sex drive, and erectile function problems.

ORGOVYX may cause fertility problems in males, which may affect your ability to father children. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of ORGOVYX. Call your doctor for medical advice about side effects or if you have a side effect that bothers you or does not go away.

You may report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

What is ORGOVYX^® (relugolix)?

ORGOVYX is a prescription medicine used in adults for the treatment of advanced prostate cancer.

It is not known if ORGOVYX is safe or effective in females or children.

Please see full Prescribing Information and Patient Product Information for ORGOVYX (relugolix). For more information about ORGOVYX, visit www.ORGOVYX.com.

PP-US-REL-2300140 05/23

2023-05-30T12:01:00

(BPT) – If you or a family member experiences allergies or asthma, you know how challenging it is to avoid triggers. When pollen is high, its effects show up immediately through irritation of your eyes, nose and throat. Plus, headaches, dizziness and fatigue may occur. The first thought may be to reduce exposure by staying indoors.

Your home should be a sanctuary, but indoor pollutants and irritants can also be triggering. Fortunately, there are proactive steps to improve your home’s indoor air quality and ensure everyone feels more comfortable. These steps can make a significant difference, especially when seasons change.

“People with allergies or asthma are often sensitive to many allergens, so tackling the problem needs a multi-pronged approach,” said Dr. John McKeon, CEO of Allergy Standards Ltd. and Principal Researcher at the iAIR Institute, “Reducing in-home allergens creates a healthier indoor environment, even during high-trigger seasons.”

In honor of National Asthma and Allergy Awareness Month, here are steps you can take to improve your indoor air quality.

1. Reduce airborne pollutants

Common sources of indoor irritants include gas stoves, cleaning supplies, paints, and wood-burning fireplaces. Some people may also have sensitivities to items like scented candles, perfumes and air freshening products. It’s wise to reduce the use of products known to cause symptoms for you or a family member.

2. Let fresh air in — not allergens

When indoor air pollutants can’t be fully eliminated, it’s a good idea to bring in fresh air while exhausting polluted air to the outside. Simply opening windows allows for air exchange but will not filter air or block allergens. Turning on fans can help circulate the air in a space but also may throw up dust into the air. An excellent way to bring cleaner air into a home is through a ventilation system paired with high efficiency filtration.

3. Change filters frequently

A dirty HVAC air filter won’t catch as many airborne particles as a clean one. A clogged filter also restricts air flow to your system, making it work harder, which adds to your energy bill and reduces the system’s life span. Improve filtration and extend the life of your machine by replacing disposable filters or cleaning reusable ones every 30-90 days in furnaces, air handlers, and air cleaners. Schedule a reminder more frequently if you have pets or suffer from asthma or allergies.

4. Add a whole-home air cleaning device

To remove harmful fine particulates, odors, allergens, mold and viruses from indoor air, consider adding a CleanEffects^® Whole Home Air Cleaner from Trane, which can remove up to 99.98% of unwanted airborne pollutants as small as .3 microns.

“No matter how clean your home is, it’s impossible to eliminate all potential allergens by vacuuming and dusting alone,” said Jennie Bergman, senior product manager of Indoor Environmental Air Quality, Trane Residential. “The CleanEffects Whole Home Air Cleaner is eight times more effective than even the best HEPA room filters, and up to 100 times more effective than a standard one-inch filter.”

The CleanEffects Whole Home Air Cleaner is also asthma & allergy friendly^® certified by the Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL), a designation given only to products scientifically proven to reduce exposure to asthma and allergy triggers.

5. Balance humidity

It is vital to maintain a balanced humidity level between 35-60%. Humid air helps mold, dust mites and other pollutants thrive. On the other hand, eyes and nasal passages can become red and irritated when the air is too dry. Monitor humidity levels through a reliable HVAC thermostat and manage those levels with a whole-home dehumidifier and/or humidifier.

If you or a family member are having allergy or asthma symptoms, first talk to your health care provider. Then, if you have concerns about your home’s indoor air quality, speak to a trusted local HVAC dealer such as a Trane Comfort Specialist, who can perform a whole-home IAQ assessment. This can help you make educated decisions based on your family’s needs and air quality concerns.

Visit Trane.com to learn more ways to improve your home’s indoor air quality.

2023-05-30T16:45:00

(BPT) – This June, the HypoPARAthyroidism Association, Inc. (HPA) is intent on making its mark within the rare disease community. In honor of World Hypoparathyroidism Awareness Day, an annual global awareness and education event observed on June 1, the nonprofit patient advocacy organization invites patients, caregivers and advocates to participate in a series of online events to raise awareness of a rare disorder that affects an estimated 77,000 to 115,000 people in the U.S. alone.

Hypoparathyroidism is a rare endocrine disorder characterized by deficient or absent parathyroid hormone (PTH) that causes lower than normal levels of calcium in the blood. PTH, which is produced by the parathyroid glands located in the neck, helps to regulate serum calcium levels in the body. It most commonly results from damage to or accidental removal of the parathyroid glands during thyroid surgery but may also be inherited or associated with other disorders.

Hypoparathyroidism can lead to a range of serious physical health complications, such as seizures, heart arrhythmias and kidney damage, and can also cause anxiety, depression and other mental health problems. As a result of these complications, patients living with hypoparathyroidism often experience a decreased quality of life.

For this year’s World Hypoparathyroidism Awareness Day, the HypoPARAthyroidism Association is hosting a Facebook Live on June 1 at 7 p.m. EST to touch on the disease prevalence, common patient diagnosis symptoms and experiences, and the need for treatment options.

The discussion will feature two leading endocrinologists in the hypoparathyroidism field, along with a patient who has been living with the disorder for over 20 years. The HPA hopes that audiences will take away an understanding of the quality-of-life impacts and emotional burden this disorder has on patients, and the urgent demand for new treatment care pathways.

As current available treatments for hypoparathyroidism — which include calcium and vitamin D supplements — only address the symptoms and not the underlying cause of the disease itself, the need for a shift to medications in the treatment paradigm is crucial.

Fortunately, there are hormone replacement medication therapies currently in development to restore normal PTH levels, with one being reviewed by the FDA. Approval of these treatments is essential to provide a safety net of options so that patients can better manage their disease and improve their quality of life.

To further broaden awareness beyond June 1, the HypoPARAthyroidism Association is excited to continue to host a series of webinars throughout June in recognition of their own hypoparathyroidism awareness month — featuring key health care professionals and company representatives to speak on a variety of relevant topics and therapy options on the horizon.

Reaching audiences through these online platforms helps the HPA to serve their mission to educate patients, physicians and the public about hypoparathyroidism, so that more research into finding new treatment options may be possible.

To learn more, visit https://hypopara.org/ or https://www.facebook.com/hypoPARAassociation/.

2023-05-26T13:01:00

(BPT) – With the World Health Organization estimating that more than 2 billion people globally lack access to safely managed drinking water at home, the topic of access to cleaner, safer drinking water has never been more important. Culligan International, a leader in water treatment solutions, is offering individuals helpful recommendations on how to ensure the water in their home is cleaner and safer to drink.

Here are a few important steps you can take:

1. Know where water contamination can occur.

Water impurities are not just limited to the water source. Contamination can also happen in the distribution system after treatment from the local municipality or private well has already occurred. While many naturally occurring chemicals and impurities are treated at municipal water treatment facilities, contamination can occur in service pipes. The best place to filter drinking water is at the point of use or your home’s tap. Those homes that utilize well water have higher risk, and homeowners should be diligent about monitoring water quality.

2. Notice any issues that may be caused by water impurities.

Some signs of problem water include corroded plumbing fixtures, unpleasant odors, disagreeable taste, discolored water and even shortened appliance lifespan. It is important to note that some water contaminants cannot be detected by taste, odor or color. In these cases, only a water test can identify an issue.

3. Schedule a test to identify impurities in your water.

Because water contamination can happen at any time and/or through a local municipality, an underground well or a homeowner’s own pipes, it is important to have your water tested by an expert who can determine the necessary steps to eliminate any harmful impurities that may be present. While testing can be done at any time, Culligan recommends scheduling a water test, especially after moving into a new house, if appliances that use water are collecting residue or burning out, and as soon as you notice a change in your water’s taste, odor or appearance. Well water should also be tested whenever any changes in your water such as color, taste, odor or cloudiness are noticed.

4. Find a filtration system that meets the needs of your home.

Water treatment solutions such as water softeners, reverse osmosis systems and specialty filters reduce specific impurities that may be found in your water. While there are many options, Culligan offers a groundbreaking system, the Aquasential^® Smart Reverse Osmosis (RO) Drinking Water System. With up to seven stages of filtration and 14 different filter options, it is certified to reduce 59 contaminants including lead, arsenic, pharmaceuticals, volatile organic compounds (VOCs) and PFOA/PFOS. The system’s modern design features a drinking water faucet with instant performance feedback in brushed nickel, chrome, matte black and bronze finishes. It also offers a smart device app that gives users intuitive control over the RO system with water alerts, maintenance needs and tools that put tracking water consumption at the tips of homeowners’ fingers.

For more information about water treatment solutions or to schedule a free in-home water test, visit www.culligan.com.